Physician profile
Bryan K Lai
NPI 1932527074
$9,363.26
in general payments reported to CMS, 2019-2025
32 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what 76% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $317 · 2021: $1,068 · 2022: $3,350 · 2023: $1,337 · 2024: $1,382 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,199.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,476.58 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $993.77 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Collegium Pharmaceutical, INC. | $366.88 | 2021-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $356.44 | 2021-2025 | Catalyft Pl Expandable Interbody System, Intellis Adaptivestim |
| Genesys Orthopedics Systems, L.L.C. | $322.25 | 2022 | |
| Vgi Medical, LLC | $272.03 | 2022 | |
| Nevro Corp. | $256.32 | 2021-2023 | Senza |
| Curonix LLC | $246.47 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $245.34 | 2022 | |
| Nalu Medical, INC. | $222.37 | 2022-2025 | Nalu Neurostimulation System |
| Si-Bone, INC. | $207.86 | 2021-2025 | |
| Scilex Pharmaceuticals INC. | $202.24 | 2021-2023 | Ztlido |
| Tersera Therapeutics LLC | $196.70 | 2019 | |
| Abbvie INC. | $158.36 | 2022-2025 | |
| Averitas Pharma INC. | $136.04 | 2023-2025 | Qutenza |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $116.46 | 2022 | |
| Vertos Medical, INC. | $83.83 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $71.88 | 2025 | Senza, Vyrsa V1 |
| Medtronic USA, INC. | $56.37 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $47.36 | 2024-2025 | |
| Pfizer INC. | $38.46 | 2023 | |
| Valinor Pharma, LLC | $36.95 | 2025 | Movantik |
| Grt US Holding, INC. | $32.15 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $31.59 | 2023-2024 | Ajovy |
| Ibsa Pharma INC. | $28.73 | 2023 | Tirosint, Licart |
| Stryker Corporation | $28.49 | 2025 | Mild Device Kit |
| Saluda Medical Americas, INC. | $26.91 | 2023-2024 | Evoke Scs, Evoke |
| Biotronik Nro, INC. | $26.70 | 2025 | Prospera |
| Biohaven Pharmaceuticals, INC. | $22.79 | 2021 | |
| Depuy Synthes Sales INC. | $20.50 | 2024 | Monovisc, Orthovisc |
| Spr Therapeutics, INC | $17.63 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.81 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.